Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial

• Published in: Clinical nutrition (Edinburgh, Scotland) Scotland), 2022-02, Vol.41 (2), p.405-414
• Main Authors: Power, Rebecca, Nolan, John M., Prado-Cabrero, Alfonso, Roche, Warren, Coen, Robert, Power, Tommy, Mulcahy, Ríona
• Format: Article
• Language: English
• Subjects: Aged; Alzheimer's disease; Carotenoids; Carotenoids - administration & dosage; Dietary Supplements; Docosahexaenoic Acids - administration & dosage; Double-Blind Method; Eicosapentaenoic Acid - administration & dosage; Fatty Acids, Omega-3 - administration & dosage; Female; Fish Oils - administration & dosage; Humans; Male; Memory, Short-Term - drug effects; Middle Aged; Neuropsychological Tests; Older adults; Omega-3 fatty acids; Randomised controlled trial; Vitamin E - administration & dosage; Working memory; Zeaxanthins - administration & dosage
• ISSN: 0261-5614; 1532-1983
• DOI: 10.1016/j.clnu.2021.12.004

Accumulating evidence suggests that omega-3 fatty acids (ω-3FAs), carotenoids and vitamin E can improve cognitive performance. However, their collective impact on cognition has not yet been investigated in healthy individuals. This study investigated the combined effect of ω-3FA, carotenoid and vitamin E supplementation on the cognitive performance of older adults. Cognitively healthy individuals aged ≥65 years consumed daily 1 g fish oil (of which 430 mg docosahexaenoic acid, 90 mg eicosapentaenoic acid), 22 mg carotenoids (10 mg lutein, 10 mg meso-zeaxanthin, 2 mg zeaxanthin) and 15 mg vitamin E or placebo for 24 months in a double-blind, placebo-controlled, randomised clinical trial. Following 24-month supplementation, individuals in the active group (n = 30; aged 69.03 ± 4.41 years; 56.7% female) recorded significantly fewer errors in working memory tasks than individuals receiving placebo (n = 30; aged 69.77 ± 3.74 years; 70% female) (point estimate effect sizes ranged 0.090–0.105). Interestingly, as the cognitive load of the working memory tasks increased, the active group outperformed the placebo group. Statistically significant improvements in tissue carotenoid concentrations, serum xanthophyll carotenoid concentrations and plasma ω-3FA concentrations were also observed in the active group versus placebo (point estimate effect sizes ranged 0.078–0.589). Moreover, the magnitude of change of carotenoid concentrations in tissue, and ω-3FA and carotenoid concentrations in blood were related to the magnitude of change in working memory performance. These results support a biologically plausible rationale whereby these nutrients work synergistically, and in a dose-dependent manner, to improve working memory in cognitively healthy older adults. Increasing nutritional intake of carotenoids and ω-3FAs may prove beneficial in reducing cognitive decline and dementia risk in later life. ISRCTN10431469; https://doi.org/10.1186/ISRCTN10431469.